{"Clinical Trial ID": "NCT00478257", "Intervention": ["INTERVENTION 1:", "Effect of light", "Effect of bright light on fatigue in women with breast cancer", "INTERVENTION 2:", "Effect of red light", "Effect of red light on fatigue in women with breast cancer"], "Eligibility": ["Incorporation criteria:", "Stage I-III Breast cancer", "\u00b7 Chemotherapy with adjuvant or neoadjuvant anthracycline", "- Exclusion criteria:", "Under 18 years of age", "Pregnancy", "- Metastatic or inoperative breast cancer (including inflammatory)", "The confusion of underlying medical diseases", "History of Mania", "History of other I-axis psychiatric disorders", "Other physical or psychological impairments"], "Results": ["Performance measures:", "Fatigue", "The short form of the multidimensional fatigue symptom inventory (MFSI-sf) was used to measure fatigue. The range of possible scores for each subscale is 0-24, and the total score range is -24-96, with a higher score indicating more severe fatigue, except for the Vigor subscale, where the higher score indicates less fatigue.", "Time frame: four cycles of chemotherapy", "Results 1:", "Title of arm/group: Effect of bright light", "Description of the arm/group: Effect of bright light on fatigue in women with breast cancer", "Total number of participants analysed: 23", "Average (standard error)", "Unit of measurement: units on a scale 15.25 (5.5)", "Results 2:", "Title of arm/group: Effect of red light", "Description of the arm/group: effect of red light on fatigue in women with breast cancer", "Total number of participants analysed: 16", "Average (standard error)", "Unit of measurement: units on a scale 21.6 (7.2)"], "Adverse Events": ["Undesirable Events 1:", "Total: 0/23 (0.00 per cent)", "Adverse Events 2:", "Total: 0/16 (0.00 per cent)"]}